Leerink Partners analsyt Joseph Schwartz raised his ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Protagonist Therapeutics (PTGX) PT Raised to $18 at BTIGAugust 7, 2018 5:01 AM Form 8-K Protagonist Therapeutics For: Aug 06August 6, 2018 7:24 AM Protagonist Therapeutics (PTGX) Secures $22 Million Equity FinancingAugust 6, 2018 7:08 AM Protagonist Therapeutics (PTGX) Says Final Results from Protagonist PROPEL Study Support Further Clinical Development of PTG-100 August 6, 2018 7:08 AM Final Results from the Protagonist PROPEL Study Support Further Clinical Development of PTG-100 for the Treatment of Ulcerative ColitisAugust 6, 2018 7:01 AM Protagonist Therapeutics Secures $22 Million Equity FinancingAugust 6, 2018 7:00 AM